Finance

Lists
ALZCUR:STO
AlzeCure Pharma AB
SEK 8.16
-3.32%
(-0.28) 1D
Sep 9, 1:44:31 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ALZCUR...
Open
SEK 8.38
High
SEK 8.38
Low
SEK 8.00
Mkt. cap
1.13B
Avg. vol.
450.16K
Volume
311.08K
P/E ratio
34.83
52-wk high
SEK 8.60
52-wk low
SEK 1.14
EPS
SEK 0.23
Shares outstanding
137.90M
No. of employees
10
Open
SEK 8.38
High
SEK 8.38
Low
SEK 8.00
Mkt. cap
1.13B
Avg. vol.
450.16K
Volume
311.08K
P/E ratio
34.83
52-wk high
SEK 8.60
52-wk low
SEK 1.14
EPS
SEK 0.23
Shares outstanding
137.90M
No. of employees
10
About AlzeCure Pharma AB
CEOMartin Jönsson
Employees10
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitealzecurepharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
97.33M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.71M
16.11M
20.68M
15.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.36M
2.91M
3.34M
4.42M
Operating expense
10.05M
18.05M
21.77M
17.09M
Total operating expenses
10.05M
18.05M
21.77M
17.09M
Operating income
-10.05M
-18.05M
-21.77M
80.23M
Other non operating income
-
-
-
-
EBT including unusual items
-10.03M
-17.75M
-21.70M
80.18M
EBT excluding unusual items
-10.03M
-17.75M
-21.70M
80.18M
Income tax expense
-4.00K
-4.00K
-2.00K
-1.00K
Effective tax rate
0.04%
0.02%
0.01%
-
Other operating expenses
-15.00K
-971.00K
-2.25M
-3.29M
Net income
-10.02M
-17.74M
-21.70M
80.18M
Net profit margin
-
-
-
82.38%
Earnings per share
-
-
-
-
Interest and investment income
102.00K
194.00K
143.00K
69.00K
Interest expense
-66.00K
-62.00K
-58.00K
-54.00K
Net interest expenses
36.00K
132.00K
85.00K
15.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.74M
-17.75M
-21.47M
80.53M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps